Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC)

Price 122.20p on 15-04-2024 at 17:03:13
Change 0.60p 0.49%
Buy 122.80p
Sell 121.80p
Buy / Sell SYNC Shares
Last Trade: Unknown 6.00 at 122.879p
Day's Volume: 497,008
Last Close: 122.20p
Open: 120.00p
ISIN: GG00B8P59C08
Day's Range 120.00p - 123.00p
52wk Range: 105.00p - 162.20p
Market Capitalisation: £800m
VWAP: 122.46439p
Shares in Issue: 654m

Recent Trades History Syncona (SYNC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 6 122.879p OTC Trade
17:03:12 - 15-Apr-24
Unknown* 29 122.943p OTC Trade
17:03:12 - 15-Apr-24
Unknown* 5,923 121.962p OTC Trade
16:36:43 - 15-Apr-24
Sell* 295 122.20p Automatic Execution
15:37:04 - 15-Apr-24
Sell* 1,471 122.20p Automatic Execution
15:37:04 - 15-Apr-24
Sell* 54,043 122.20p Uncrossing Trade
15:35:26 - 15-Apr-24
Sell* 1,373 121.80p Automatic Execution
15:29:35 - 15-Apr-24
Sell* 96 121.80p Automatic Execution
15:29:30 - 15-Apr-24
Sell* 5,772 121.80p Automatic Execution
15:29:30 - 15-Apr-24
Sell* 541 121.80p Automatic Execution
15:29:30 - 15-Apr-24

Share Price History for Syncona

Time period:
to
Date Open High Low Close Volume

Share News for Syncona

Syncona agrees to sell stake in investee company for GBP7.4 million

11th Apr 2024 14:22

(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Therapeutics Inc. Read More

IN BRIEF: Syncona notes investee Achilles's annual loss narrows

4th Apr 2024 17:06

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million in 2023 from USD71.1 million in 2022. General and administrative costs contract by 19% to USD17.0 million from USD21.1 million. According to Syncona's website, the company has a 25% stake in Achilles. Read More

Syncona portfolio company Autolus posts widened loss for 2023

14th Mar 2024 14:16

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an increase in annual expenses. Read More

IN BRIEF: Freeline shareholders approve Syncona acquisition

12th Feb 2024 18:01

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona. Read More

UPDATE: Syncona portfolio strengthens thanks to Autolus

8th Feb 2024 13:45

(Alliance News) - Syncona Ltd on Thursday said its portfolio company Autolus Therapeutics PLC has struck a deal to work with BioNTech to commercialise its CAR-T programmes. Read More

FTSE 100 Latest
Value7,965.53
Change-30.05

Login to your account

Forgot Password?

Not Registered